Rare Diseases Get Some Much-Needed Face Time
New Technology Essentially Crowd Sources Phenotypic Information to Improve Diagnostics
In Gainesville, Biopharma Finds a Place in the Sun
Florida Region Has a Top-Tier Incubator, Recognized Schools, and Growing Companies
The Future Is Fluid
Liquid Biopsy Has Proven Its Mettle in the Fight against NSCLC and May Soon Also Be Standard of Care in Other Cancers
Genomics Brings Heavy Lifting to Immuno-Oncology
The Synergy of Two Burgeoning Fields Will Lead to Improved Precision Medicine
GEN Publishing Introduces "Clinical OMICS" Digital Publication
New Rochelle, NY, April 24, 2014—GEN Publishing recently introduced “Clinical OMICS,” a semi-monthly digital publication focusing on the application of OMICS technologies in clinical settings. These advanced techniques, such as next-gen sequencing, are beginning to transform medical care just as they revolutionized basic life science research over the past decade-and-a-half.
“GEN’s editors and reporters have written about the research use of pharmacogenomics, genomics, metabolomics, transcriptomics, etc. etc. for years,” said John Sterling, editor-in-chief of Genetic Engineering & Biotechnology News (GEN). “The rapid advance of OMICS technologies has reached the point where we are convinced that the time is now for a new publication that shows how these diagnostic methodologies are dramatically impacting clinical practice.”
Clinical OMICS is directed at clinical lab directors and managers, oncologists, infectious disease specialists, and cardiologists. Intended to serve as a resource for the development and standardization of best OMICS practices, Clinical OMICS provides critical information and insights on the trend toward personalized medicine.
The premier issue contains articles on translating OMICs into cancer biology and medicine, how payers are grappling with reimbursement issues, a profile of Lawrence Brody, who is overseeing NHGRI’s new division of genomics and society, the move of next-gen sequencing systems into the clinic, and a case study of a genomics test for coronary artery disease. Late-breaking clinical OMICs news, OMICS-related clinical APPS, and new products are also featured.